Gain access to exclusive preclinical content.
Complete the form below. We'll assign a user name and password, then send you a link. Thanks!

Get Access Register

EXCLUSIVE PRECLINICAL CONTENT.
You must log in to access content on this page. Or click here to request access.
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI

Francesco Trepiccione, Anna Iervolino, Mariavittoria D’Acierno, Sabrina Siccardi, Vincenzo Costanzo, Donato Sardella, Luigi R. De La Motte, Luciano D’Apolito, Antonio Miele, Alessandra F. Perna, Giovanna Capolongo, Miriam Zacchia, Sebastian Frische, Rikke Nielsen,Leopoldo Staiano4,5, Irene Sambri, Rossella De Cegli, Robert Unwin, Dominique Eladari, Giovambattista Capasso, "The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI", Science Translational Medicine, November 2023, Med. 15, eabn4214 (2023).